PORTLAND, Ore.

俄勒冈州波特兰

,

，

June 4, 2026

/PRNewswire/ -- ALS Northwest is accelerating progress in ALS research through continued investment and deepened national collaboration, reinforcing a shared commitment to advancing treatment, prevention, and understanding of the disease.

/美通社/ -- ALS Northwest 通过持续投资和深化全国合作，加速肌萎缩侧索硬化症（ALS）研究进展，进一步巩固了在推进该疾病治疗、预防和认知方面的共同承诺。

In partnership with fellow member organizations of ALS United, ALS Northwest continues to support a growing portfolio of Collaborative Research Innovation Grants, fueling bold scientific ideas and cross-institutional collaboration designed to move the field forward faster.

ALS Northwest 与 ALS United 的其他成员组织携手合作，持续支持日益扩大的“协作研究创新资助”项目组合，推动大胆的科学构想和跨机构合作，以加速该领域的发展。

'Advancing research is not optional, it's urgent,' said Cassy Adams, ALS Northwest, Executive Director. 'By investing in innovative science and working collectively across the ALS community, we are helping unlock new possibilities that can change the trajectory of this disease.'

“推进研究并非可选项，而是当务之急，”ALS西北区执行董事卡西·亚当斯表示。“通过投资创新科学，并在ALS社区内开展集体协作，我们正在帮助开启新的可能性，从而改变这种疾病的发展轨迹。”

A portion of ALS Northwest's funding supports the work of Faranak Fattahi, PhD; Associate Professor, Department of Cellular and Molecular Pharmacology, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San Francisco and collaborator, Sarah Kishinevsky, PhD, the co-founder and CEO of EverTree Bio..

ALS西北分部部分资金用于支持Faranak Fattahi博士（加州大学旧金山分校细胞与分子药理学系副教授、伊莱和埃迪特·布罗德再生医学与干细胞研究中心成员）及其合作者Sarah Kishinevsky博士（EverTree Bio联合创始人兼首席执行官）的研究工作。

Dr. Fattahi's project, the 'Evaluation of Glioprotective Small Molecules for ALS Therapy,' tests the hypothesis that certain support cells in the nervous system, called glial cells, may play a significant role in causing ALS progression, not just reacting to it. This project tests new drug compounds designed to protect these support cells from stress, with the goal of slowing or preventing damage to motor neurons and muscles in ALS..

法塔希博士的项目“用于肌萎缩侧索硬化症治疗的胶质保护性小分子评估”验证了以下假设：神经系统中被称为胶质细胞的某些支持细胞可能在肌萎缩侧索硬化症（ALS）的进展中发挥重要作用，而不仅仅是对疾病作出反应。该项目测试了旨在保护这些支持细胞免受应激损伤的新药物化合物，目标是减缓或预防ALS对运动神经元和肌肉的损害。

The team will study whether strengthening these support cells can preserve movement, muscle function, and survival across multiple forms of ALS. The approach could open a new and complementary path for ALS treatment alongside therapies that directly target motor neurons.

该团队将研究增强这些支持细胞是否能够在多种形式的肌萎缩侧索硬化症（ALS）中保持运动能力、肌肉功能和生存率。这种方法可能为ALS治疗开辟一条新的补充路径，与直接针对运动神经元的疗法相辅相成。

Through strategic funding and partnership, ALS Northwest is helping sustain momentum and ensure promising discoveries to move forward.

通过战略性资金支持和伙伴关系，ALS Northwest 正在帮助维持发展势头，并确保有前景的发现得以持续推进。

The collaborative research program, facilitated by ALS Network, maximizes impact by streamlining infrastructure, reducing duplication, and directing more resources toward high-potential research.

由ALS网络促成的合作研究计划通过优化基础设施、减少重复工作，并将更多资源导向高潜力研究，从而最大化其影响力。

Together, these efforts reflect a shared commitment to advancing research, strengthening care, and driving advocacy, ensuring continued progress and hope for people living with ALS and their loved ones.

这些共同努力体现了我们在推进研究、加强护理和推动倡导方面的共同承诺，确保为肌萎缩侧索硬化症（ALS）患者及其亲人带来持续的进步与希望。

Learn more at:

了解更多，请访问：

ALS Northwest Research

ALS 西北研究

Media Contact:

媒体联系人：

Jennifer Jordan,

詹妮弗·乔丹，

[email protected]

[email protected]

SOURCE ALS United

来源：美国肌萎缩侧索硬化症协会

21

二十一

%

%

more press release views with

更多新闻稿浏览量，使用

Request a Demo

申请演示